Amicogen, Inc. (KOSDAQ:092040)
South Korea · Delayed Price · Currency is KRW 1,268.00
-41.00 (-3.13%)
Jun 10, 2026, 3:30 PM KST
Amicogen Market Cap
Amicogen has a market cap or net worth of 89.33 billion as of June 10, 2026. Its market cap has decreased by -48.59% in one year.
Market Cap
89.33B
Enterprise Value
144.75B
Revenue
43.44B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,268.00
Market Cap Chart
Since September 12, 2013, Amicogen's market cap has decreased from 237.19B to 89.33B, a decrease of -62.34%. That is a compound annual growth rate of -7.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 89.33B | -9.72% |
| Dec 30, 2025 | 98.95B | -53.23% |
| Dec 30, 2024 | 211.59B | -48.65% |
| Dec 28, 2023 | 412.06B | 8.63% |
| Dec 29, 2022 | 379.32B | -38.89% |
| Dec 30, 2021 | 620.70B | -14.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genexine | 151.90B |
| Macrogen | 135.08B |
| Vaxcell-Bio Therapeutics | 119.08B |
| MedPacto | 118.76B |
| ENCell | 101.32B |
| GeneOne Life Science | 98.38B |
| iNtRON Biotechnology | 84.88B |
| Prestige BioPharma | 81.61B |